5 News & Press Releases found
Locate Bio Limited News
-
Locate Bio Closes £10 million Funding Round
Funding to further advance Locate Bio’s regenerative medicine pipeline of orthobiologics Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that it has raised an oversubscribed £10 million of ...
-
Locate Bio’s Chondro3 Granted FDA Breakthrough Device Designation
The Company’s second FDA Breakthrough Device designation granted in 2021 Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...
-
CognitOss Granted FDA Breakthrough Device Designation
FDA’s Breakthrough Device Program helps accelerate patient access to more effective treatments Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has ...
-
Locate Bio appoints Keith Valentine as the Non-Executive Chair of the Board of Directors
Another important step towards its ambition of building a world leading, diversified orthobiologics company Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce the appointment of Keith Valentine as the ...
-
Locate Bio acquires complementary late stage orthobiologics assets
Locate Bio, an orthobiologics focused regenerative medicine company, today announced the in-licencing of multiple late stage orthobiologics assets from RCSI University of Medicine and Health Sciences. The technologies developed by the RCSI Tissue ...